Health
16 Oct 2026
Stryker’s Sonopet 3 ultrasonic platform receives FDA 510(k) clearance
The U.S. Food and Drug Administration has granted Stryker a 510(k) clearance for its Sonopet 3 ultrasonic platform, with first clinical cases expected in October 2026 and a commercial launch slated for later that fall.
Read more